AMR vs Equatorial Guinea: Hepatitis B surface antigen (HBsAg) prevalence (%)
AMR
0.0%
in 2024
Equatorial Guinea
2.0%
in 2024
AMR rank
12th
Equatorial Guinea rank
12th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- AMR
- Equatorial Guinea
How they compare
Equatorial Guinea currently reports 2.0% against 0.0% in AMR, a difference of 2.0%.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
AMR ranks 12th and Equatorial Guinea ranks 12th of 13 groups.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | AMR | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 2.3% | 2.3% | Equatorial Guinea |
| 2020s | 0.0% | 2.1% | 2.1% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, AMR or Equatorial Guinea?
- Equatorial Guinea, at 2.0% against 0.0% in AMR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between AMR and Equatorial Guinea?
- 2.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for AMR and Equatorial Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do AMR and Equatorial Guinea rank globally for hepatitis b surface antigen (hbsag) prevalence?
- AMR ranks 12th and Equatorial Guinea ranks 12th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.